Larvol Delta - Annovis-Bio-Announces-First-Patient-Dosed-in-Phase-3-Trial-in-Patients-with-Early-Parkinson39s-Disease

Posiphen (buntanetap) - Annovis Bio

https://www.prnewswire.com/news-releases/annovis-bio-announces-first-patient-dosed-in-phase-3-trial-in-patients-with-early-parkinsons-disease-301611287.html

Aug 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next